Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > F Douglas Kling > Profile

F Douglas Kling

Affiliations

  • Chief Operating Officer at Newamsterdam Pharma Co N.v. (NAMS), 2025-02-20
  • See Remarks at Matinas Biopharma Holdings Inc. (MTNB), 2017-03-01
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
Newamsterdam Pharma Co N.v.
 NAMS $0.00 9,218 44,000 2025-02-19 Filing
Newamsterdam Pharma Co N.v.
 NAMS $0.00 90,782 44,000 2025-02-18 Filing
Newamsterdam Pharma Co N.v.
 NAMS $0.00 8,914 44,000 2025-01-30 Filing
Newamsterdam Pharma Co N.v.
 NAMS $0.00 4,664 52,914 2025-01-30 Filing
Newamsterdam Pharma Co N.v.
 NAMS $0.00 56,863 44,000 2025-01-29 Filing